{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:20:33Z","timestamp":1761675633652},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.vaccine.2008.12.004","type":"journal-article","created":{"date-parts":[[2008,12,28]],"date-time":"2008-12-28T09:48:52Z","timestamp":1230457732000},"page":"1230-1241","source":"Crossref","is-referenced-by-count":34,"title":["New approach on the development of a mucosal vaccine against strangles: Systemic and mucosal immune responses in a mouse model"],"prefix":"10.1016","volume":"27","author":[{"given":"H.F.","family":"Florindo","sequence":"first","affiliation":[]},{"given":"S.","family":"Pandit","sequence":"additional","affiliation":[]},{"given":"L.M.D.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"H.O.","family":"Alpar","sequence":"additional","affiliation":[]},{"given":"A.J.","family":"Almeida","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2008.12.004_bib1","first-page":"385","article-title":"Systemic Streptococcus equi infection in a horse handler\u2014a case of human strangles","volume":"145","author":"Breiman","year":"1986","journal-title":"West J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2008.12.004_bib2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1469-0691.2003.00663.x","article-title":"Streptococcus equi subspecies equi (Lancefield group C) meningitis in a child","volume":"9","author":"Welsayed","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2008.12.004_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1892\/0891-6640(2005)19<123:SEIIHG>2.0.CO;2","article-title":"Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles","volume":"19","author":"Sweeney","year":"2005","journal-title":"J Vet Intern Med"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.004_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.tvjl.2006.05.011","article-title":"Getting a grip on strangles: recent progress towards improved diagnostics and vaccines","volume":"173","author":"Waller","year":"2007","journal-title":"Vet J"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.004_bib5","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1128\/IAI.72.6.3228-3236.2004","article-title":"Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses","volume":"72","author":"Flock","year":"2004","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2008.12.004_bib6","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1128\/IAI.68.10.6048-6051.2000","article-title":"Identification of lipoprotein homologues of pneumococcal PsaA in the equine pathogens Streptococcus equi and Streptococcus zooepidemicus","volume":"68","author":"Harrington","year":"2000","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2008.12.004_bib7","doi-asserted-by":"crossref","first-page":"6907","DOI":"10.1128\/IAI.01116-06","article-title":"Mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation","volume":"74","author":"Hamilton","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.12.004_bib8","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0264-410X(01)00488-1","article-title":"Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin","volume":"20","author":"Sheoran","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.004_bib9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.2042-3306.1985.tb02505.x","article-title":"Serum bactericidal responses to Streptococcus equi of horses following infection or vaccination","volume":"17","author":"Timoney","year":"1985","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2008.12.004_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0264-410X(00)00187-0","article-title":"Induction of mucosal and systemic antibody specific for SeMF3 of Streptococcus equi by intranasal vaccination using a sucrose acetate isobutyrate based delivery system","volume":"19","author":"Nally","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.004_bib11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1163\/156856299X00892","article-title":"Intranasal immunization against influenza virus using polymeric particles","volume":"10","author":"Lemoine","year":"1999","journal-title":"J Biomater Sci Polym Ed"},{"key":"10.1016\/j.vaccine.2008.12.004_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.2042-7158.1993.tb05532.x","article-title":"Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(l-lactic acid) microspheres in rats, rabbits and guinea-pigs","volume":"45","author":"Almeida","year":"1993","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.vaccine.2008.12.004_bib13","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/S0264-410X(98)00089-9","article-title":"Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal, intra-muscular administration of microsphere co-encapsualted Yersinia pestis sub-unit vaccines","volume":"16","author":"Eyles","year":"1998","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.004_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1016104910582","article-title":"Recent advances in vaccine adjuvants","volume":"19","author":"Singh","year":"2002","journal-title":"Pharm Res"},{"issue":"19","key":"10.1016\/j.vaccine.2008.12.004_bib15","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1016\/j.vaccine.2006.01.011","article-title":"Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally","volume":"24","author":"Jaganathan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.004_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2005.04.037","article-title":"Preparation of coated nanoparticles for a new mucosal vaccine delivery system","volume":"299","author":"Borges","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2008.12.004_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00726-007-0532-1","article-title":"Enhancement of intestinal absorption of macromolecules by spermine in rats","volume":"33","author":"Sugita","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.vaccine.2008.12.004_bib18","article-title":"Surfactants in vaccine adjuvants: description and perspectives","volume":"24S2","author":"Ascarateil","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.004_bib19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biomaterials.2008.10.035","article-title":"The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-\u025b-caprolactone-based nanoparticles","volume":"30","author":"Florindo","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2008.12.004_bib20","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1016\/j.vaccine.2008.05.074","article-title":"S. equi antigens adsorbed onto surface modified poly-caprolactone microspheres induce humoral and cellular specific immune responses","volume":"26","author":"Florindo","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.004_bib21","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Procedure and some applications","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.12.004_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2008.12.004_bib23","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.173.5.3148","article-title":"Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors","volume":"173","author":"Fifis","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.12.004_bib24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijpharm.2007.02.008","article-title":"Glycol chitosan as a stabilizer for protein encapsulated into poly(lactide-co-glycolide) microparticle","volume":"338","author":"Lee","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2008.12.004_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-7799(00)01437-2","article-title":"Ambiguities in the preclinical quality assessment of microparticulate vaccines","volume":"18","author":"Johansen","year":"2000","journal-title":"Trends Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.004_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0939-6411(00)00079-5","article-title":"Revisiting PLA\/PLGA microspheres: an analysis of their potential in parenteral vaccination","volume":"50","author":"Johansen","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2008.12.004_bib27","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0264-410X(98)00372-7","article-title":"Induction of cellular immunity to a mycobacterial antigen adsorbed on lamellar particles of lactide polymers","volume":"17","author":"Venkataprasad","year":"1999","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.004_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejpb.2006.04.007","article-title":"Microencapsulation of Streptococcus equi antigens in biodegradable microspheres and preliminary immunisation studies","volume":"64","author":"Azevedo","year":"2006","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.vaccine.2008.12.004_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0264-410X(02)00435-8","article-title":"Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres","volume":"21","author":"Gutierro","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.004_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-409X(97)00066-5","article-title":"Large molecule and particulate uptake in nasal cavity: the effect of size on nasal absorption","volume":"29","author":"Donovan","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2008.12.004_bib31","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0264-410X(96)00099-0","article-title":"Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity","volume":"14","author":"Nixon","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.004_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0168-3659(96)01484-8","article-title":"Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery","volume":"43","author":"Song","year":"1997","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2008.12.004_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpharm.2005.05.028","article-title":"Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles","volume":"301","author":"Katare","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2008.12.004_bib34","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1016\/S0264-410X(01)00220-1","article-title":"Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration","volume":"19","author":"Eyles","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.004_bib35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0264-410X(02)00531-5","article-title":"Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro","volume":"21","author":"Sun","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.004_bib36","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0264-410X(97)00021-2","article-title":"Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice","volume":"15","author":"Hordnes","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.004_bib37","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1128\/IAI.72.8.4368-4375.2004","article-title":"Intranasal co-administration of the Cry1Ac protoxin with amoebal lysates increases protection against Naegleria fowleri meningoencephalitis","volume":"72","author":"Rojas-Hernandez","year":"2004","journal-title":"Infect Immun"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2008.12.004_bib38","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1016\/S0264-410X(03)00305-0","article-title":"The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines","volume":"21","author":"Baudner","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.004_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-5173(99)00030-7","article-title":"Effect of chitosan on epithelial permeability and structure","volume":"182","author":"Dodane","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2008.12.004_bib40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.addr.2004.09.003","article-title":"Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens","volume":"57","author":"Jiang","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2008.12.004_bib41","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.4049\/jimmunol.162.6.3559","article-title":"Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production","volume":"162","author":"Yanagita","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.12.004_bib42","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/S0264-410X(03)00078-1","article-title":"Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia","volume":"21","author":"Ito","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.12.004_bib43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.vetmic.2006.07.004","article-title":"Encapsulation of antigenic extracts of Salmonella enterica serovar Abortusovis into polymeric systems and efficacy as vaccines in mice","volume":"118","author":"Estevan","year":"2006","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2008.12.004_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0264-410X(00)00163-8","article-title":"In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity","volume":"19","author":"Ludewig","year":"2000","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2008.12.004_bib45","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.vaccine.2005.09.007","article-title":"Modulating the adjuvanticity of alum by co-administration of muramyl di-peptide (MDP) or Quil-A","volume":"24","author":"Moschos","year":"2006","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08017337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08017337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T05:45:48Z","timestamp":1684820748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08017337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0264410X08017337"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.12.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}